Results overview: Found 1 records in 0.01 seconds.
Articles, 1 records found
Articles 1 records found  
1.
12 p, 1.2 MB The cost-effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain / Azanza Perea, José Ramón (Clínica Universidad de Navarra) ; Grau, Santiago (Hospital del Mar (Barcelona, Catalunya)) ; Vázquez, Lourdes (Hospital Clínico Universitario (Salamanca)) ; Rebollo, Pablo (Ingress-health) ; Peral, Carmen (Pfizer) ; López-Ibáñez de Aldecoa, Alejandra (Pfizer) ; López-Gómez, Vanessa (Pfizer) ; Universitat Autònoma de Barcelona
Invasive mould diseases are associated with high morbidity, mortality and economic impact. Its treatment is often started prior to differential pathogen diagnosis. Isavuconazole is approved for treatment of invasive aspergillosis (IA) and invasive mucormycosis (IM) when amphotericin-B is not indicated. [...]
2020 - 10.1111/myc.13189
Mycoses, Vol. 64 (october 2020) , p. 66-77  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.